|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brandsma D, Stalpers L, Taal W, Sminia P
and van den Bent MJ: Clinical features, mechanisms, and management
of pseudoprogression in malignant gliomas. Lancet Oncol. 9:453–461.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis FG, Freels S, Grutsch J, Barlas S
and Brem S: Survival rates in patients with primary malignant brain
tumors stratified by patient age and tumor histological type: An
analysis based on Surveillance, Epidemiology, and End Results
(SEER) data, 1973–1991. J Neurosurg. 88:1–10. 2008. View Article : Google Scholar
|
|
4
|
Penas-Prado M and Gilbert MR: Molecularly
targeted therapies for malignant gliomas: Advances and challenges.
Expert Rev Anticancer Ther. 7:641–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tachon G, Masliantsev K, Rivet P,
Petropoulos C, Godet J, Milin S, Wager M, Guichet PO and
Karayan-Tapon L: Prognostic significance of MEOX2 in gliomas. Mod
Pathol. 32:774–786. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Komori T, Sasaki H and Yoshida K: Revised
WHO classification of tumours of the central nervous system:
Summary of the revision and perspective. No Shinkei Geka.
44:625–635. 2016.(In Japanese). PubMed/NCBI
|
|
7
|
Wolf A, Agnihotri S and Guha A: Erratum:
Targeting metabolic remodeling in glioblastoma multiforme.
Oncotarget. 9:348552018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khosla D: Concurrent therapy to enhance
radiotherapeutic outcomes in glioblastoma. Ann Transl Med.
4:542016.PubMed/NCBI
|
|
9
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu P, Yang J, Liu J, Yang X, Liao J, Yuan
F, Xu Y, Liu B and Chen Q: Identification of glioblastoma gene
prognosis modules based on weighted gene co-expression network
analysis. BMC Med Genomics. 11:962018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao XF, He HQ, Zhu XB, Xie SL and Cao Y:
lncRNA SNHG20 promotes tumorigenesis and cancer stemness in
glioblastoma via activating PI3K/Akt/mTOR signaling pathway.
Neoplasma. 66:532–542. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hudson K, Hancox UJ, Trigwell C, McEwen R,
Polanska UM, Nikolaou M, Morentin Gutierrez P, Avivar-Valderas A,
Delpuech O, Dudley P, et al: Intermittent high dose scheduling of
AZD8835, a novel selective inhibitor of PI3Kα and PI3Kδ,
demonstrates treatment strategies for PIK3CA-dependent breast
cancers. Mol Cancer Ther. 15:877–889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu JZ, Ying Y, Liu Y, Sun CB, Dai C, Zhao
S, Tian SZ, Peng J, Han NP, Yuan JL, et al: Antifibrotic action of
Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling
pathway in mouse model of pulmonary fibrosis. Biomed Pharmacother.
118:1092932019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitchison HM and Mole SE:
Neurodegenerative disease: The neuronal ceroid lipofuscinoses
(Batten disease). Curr Opin Neurol. 14:795–803. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Savukoski M, Klockars T, Holmberg V,
Santavuori P and Peltonen L: CLN5, a novel gene encoding a putative
transmembrane protein mutated in Finnish variant late infantile
neuronal ceroid lipofuscinosis. Nat Genet. 19:286–288. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vesa J, Chin MH, Oelgeschläger K,
Isosomppi J, DellAngelica EC, Jalanko A and Peltonen L: Neuronal
Ceroid Lipofuscinoses Are Connected at Molecular Level: Interaction
of CLN5 Protein with CLN2 and CLN3. Mol Biol Cell. 13:2410–2420.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lebrun AH, Storch S, Rüschendorf F,
Schmiedt ML, Kyttälä A, Mole SE, Kitzmüller C, Saar K, Mewasingh
LD, Boda V, et al: Retention of lysosomal protein CLN5 in the
endoplasmic reticulum causes neuronal ceroid lipofuscinosis in
Asian sibship. Hum Mutat. 30:E651–E61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bouhamdani N, Comeau D, Cormier K and
Turcotte S: STF-62247 accumulates in lysosomes and blocks late
stages of autophagy to selectively target von
Hippel-Lindau-inactivated cells. Am J Physiol Cell Physio.
316:C605–C620. 2019. View Article : Google Scholar
|
|
19
|
Jia R and Bonifacino JS: Lysosome
positioning influences mTORC2 and AKT signaling. Mol Cell.
75:26–38.e3. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Z, Li C, Kang B, Ge G, Li C and Zhang
Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bahadur S, Sahu AK, Baghel P and Saha S:
Current promising treatment strategy for glioblastoma multiform: A
review. Oncol Rev. 13:417:2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yilmaz M, Christofori G and Lehembre F:
Distinct mechanisms of tumor invasion and metastasis. Trends Mol
Med. 13:535–541. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schrump DS, Chen A and Consoli U:
Inhibition of lung cancer proliferation by antisense cyclin D.
Cancer Gene The. 3:131–135. 1996.
|
|
25
|
Stewart CJ and Crook ML: CD147 (EMMPRIN)
and matrix metalloproteinase-2 expression in uterine endometrioid
adenocarcinoma. Pathol Res Pract. 207:30–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoshyar R, Bathaie SZ and Sadeghizadeh M:
Crocin Triggers the apoptosis through increasing the Bax/Bcl-2
ratio and caspase activation in human gastric adenocarcinoma, AGS,
cells. DNA Cell Biol. 32:50–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Viallard JF, Lacombe F, Belloc F,
Pellegrin JL and Reiffers J: Molecular mechanisms controlling the
cell cycle: Fundamental aspects and implications for oncology.
Cancer Radiother. 5:109–129. 2001.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang HL, Kuo YH, Tsai CT, Huang YT, Chen
SC, Chang HW, Lin E, Lin WH and Hseu YC: Anti-metastatic activities
of Antrodia camphorata against human breast cancer cells
mediated through suppression of the MAPK signaling pathway. Food
Chem Toxicol. 49:290–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
